Email address
[email protected]Contact number
+1 973 643 7000About
Provided by Sills Cummis & Gross P.C.
The firm's highly credentialed and experienced Corporate Department attorneys handle a broad range of public and private transactional, compliance and corporate counsel assignments for international and domestic investors, lenders, entrepreneurs, franchisors and franchisees, and operating companies, from startups to small and midsized entities to Fortune 500 corporations.
The firm's attorneys partner with in-house counsel, management and boards of directors in the design and implementation of all facets of their day-to-day and non-ordinary course legal activities, initiatives and strategic decisions, including, mergers and acquisitions, joint ventures and corporate collaborations, capital market and securities transactions, credit facilities, restructurings and workouts, corporate governance, commercial transactions such as licensing, distribution, supply and consulting arrangements, executive compensation and general corporate matters.
The Department's deal volume combined with its specific industry experience allow Sills Cummis & Gross to provide creative and pragmatic advice regarding deal structures, industry trends and market terms. Members of the Firm actively manage each assignment and recognize the importance of delivering solutions calibrated to the client and the size and complexity of the matter at hand.
Chambers Review
Sills Cummis & Gross P.C. offers clients a sophisticated corporate service, with expertise in M&A and a variety of other commercial transactions. The firm's expertise spans a range of industries, including healthcare, entertainment, manufacturing and construction. Clients include Fortune 500 companies, midmarket businesses and startups.
Notable Practitioners
Steven Gross's experience includes advising companies on securities offerings and other corporate and financing matters.
Managing partner Max Crane possesses broad expertise across the spectrum of corporate matters, including M&A and financings.
Ira Rosenberg routinely represents pharmaceutical companies in acquisitions, licensing matters and collaboration agreements.